ArticleOncology letters2018

miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP-α in glioblastoma.

Yun-Na Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.